Information Provided By: 
Fly News Breaks for May 29, 2015
SPLK
May 29, 2015 | 09:20 EDT
After Splunk's Q1 billings, revenue and operating margin all beat guidance and/or Street expectations, Stifel said its believes the company has a number of drivers that can lead to double-digit revenue growth and the likelihood for its coming quarters to continue topping consensus expectations. The firm added that it thinks Splunk's premium is warranted and its maintains its Buy rating and $82 price target on the stock.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
